With more than eight years of radiation oncology experience across three states, Dr Bucknell brings a comprehensive, patient-centred approach to his practice. He is committed to improving indigenous cancer care and ensuring rural and regional cancer patients receive access to the best possible treatment.
Dr Nicholas Bucknell is an experienced radiation oncologist at Icon Cancer Centre Rockingham. In 2012 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Western Australia and subsequently undertook specialist radiation oncology training in Victoria and Tasmania. Dr Bucknell completed a clinical research fellowship at Peter MacCallum Cancer Centre where he gained extensive experience in managing a broad range of cancer types. In 2021 he became a fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) and undertook a radiation oncology position at Peter MacCallum Cancer Centre.
Dr Bucknell maintains a strong interest in clinical research and trials with a particular focus on lung cancer and stereotactic ablative radiation therapy (SABR). He enjoys a mixture of clinical work, contributing to leading national and international publications and conferences, and attending regular multidisciplinary meetings with his colleagues. In addition to his role at Icon, Dr Bucknell is a radiation oncologist at Sir Charles Gairdner Hospital. He is also a member of several leading cancer trial groups including the American Society of Radiation Oncology (ASTRO), European Society for Radiotherapy and Oncology (ESTRO) and Trans Tasman Oncology Group (TROG). Dr Bucknell has been awarded a number of RANZCR prizes and research grants including the Varian Prize for best trainee oral presentation at the 2018 annual scientific meeting and the Withers and Peters Scholarship in 2021.
His clinical experience covers a broad range of solid tumour malignancies with a special interest in lung cancer, gastrointestinal cancer, colorectal cancer, skin cancer, brain cancer and spinal (CNS), and stereotactic radiation therapy.